Oneview Healthcare PLC (ONE.AX)
AUD 0.3
(-1.64%)
AUD 0.3
(-1.64%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -10.61 Million EUR | -80.9% |
| 2022 | -5.86 Million EUR | 58.01% |
| 2021 | -13.97 Million AUD | -163.99% |
| 2020 | -5.29 Million AUD | 37.9% |
| 2019 | -8.52 Million AUD | 8.67% |
| 2018 | -9.33 Million AUD | 67.39% |
| 2017 | -28.61 Million AUD | 18.46% |
| 2016 | -35.08 Million AUD | 28.25% |
| 2015 | -48.9 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -5.97 Million EUR | 43.72% |
| 2024 Q2 | -5.97 Million EUR | 20.95% |
| 2023 Q3 | -10.76 Million EUR | -523.94% |
| 2023 Q4 | -10.61 Million EUR | 1.42% |
| 2023 FY | -10.61 Million EUR | -80.9% |
| 2023 Q2 | -1.72 Million EUR | 0.0% |
| 2023 Q1 | -1.72 Million EUR | 70.59% |
| 2022 Q2 | -14.12 Million EUR | -2.64% |
| 2022 FY | -5.86 Million EUR | 58.01% |
| 2022 Q1 | -13.75 Million EUR | 1.52% |
| 2022 Q4 | -5.86 Million EUR | 2.85% |
| 2022 Q3 | -6.03 Million EUR | 57.24% |
| 2021 Q1 | -6.33 Million EUR | 24.96% |
| 2021 Q2 | -6.49 Million EUR | -2.48% |
| 2021 Q3 | -22.97 Million EUR | -253.99% |
| 2021 Q4 | -13.97 Million AUD | 39.2% |
| 2021 FY | -13.97 Million AUD | -163.99% |
| 2020 FY | -5.29 Million AUD | 37.9% |
| 2020 Q4 | -8.44 Million AUD | 8.3% |
| 2020 Q3 | -9.2 Million EUR | -66.54% |
| 2020 Q2 | -5.52 Million EUR | 9.14% |
| 2020 Q1 | -6.08 Million EUR | 28.61% |
| 2019 Q1 | -27.03 Million EUR | -189.72% |
| 2019 Q2 | -27.71 Million EUR | -2.53% |
| 2019 Q3 | -14.15 Million EUR | 48.94% |
| 2019 Q4 | -8.52 Million AUD | 39.79% |
| 2019 FY | -8.52 Million AUD | 8.67% |
| 2018 Q4 | -9.33 Million AUD | 37.74% |
| 2018 FY | -9.33 Million AUD | 67.39% |
| 2018 Q1 | -28 Million EUR | 2.1% |
| 2018 Q2 | -27.55 Million EUR | 1.61% |
| 2018 Q3 | -14.98 Million EUR | 45.62% |
| 2017 Q4 | -28.61 Million AUD | 33.64% |
| 2017 Q3 | -43.11 Million EUR | -28.16% |
| 2017 Q2 | -33.64 Million EUR | -6.42% |
| 2017 Q1 | -31.61 Million EUR | 9.9% |
| 2017 FY | -28.61 Million AUD | 18.46% |
| 2016 Q3 | -51.49 Million EUR | 20.46% |
| 2016 FY | -35.08 Million AUD | 28.25% |
| 2016 Q2 | -64.73 Million EUR | -0.6% |
| 2016 Q1 | -64.34 Million EUR | -237.85% |
| 2016 Q4 | -35.08 Million AUD | 31.86% |
| 2015 Q4 | -19.04 Million EUR | 6.06% |
| 2015 Q1 | 9.79 Million EUR | 0.0% |
| 2015 FY | -48.9 Million AUD | 0.0% |
| 2015 Q3 | -20.27 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alcidion Group Limited | -10.1 Million AUD | -5.053% |
| Artrya Limited | -6.18 Million AUD | -71.601% |
| Beamtree Holdings Limited | -4.5 Million AUD | -135.646% |
| Cogstate Limited | -44.09 Million AUD | 75.933% |
| Careteq Limited | -1.24 Million AUD | -751.102% |
| Doctor Care Anywhere Group PLC | 9.22 Million AUD | 215.023% |
| Emyria Limited | -752.53 Thousand AUD | -1310.365% |
| Global Health Limited | -1.03 Million AUD | -921.155% |
| HITIQ Limited | 2.23 Million AUD | 574.338% |
| Intelicare Holdings Limited | -221.8 Thousand AUD | -4684.974% |
| ImExHS Limited | -1.06 Million AUD | -893.197% |
| Mach7 Technologies Limited | -24.9 Million AUD | 57.388% |
| MedAdvisor Limited | -3.22 Million AUD | -228.836% |
| Oakridge International Limited | -929.02 Thousand AUD | -1042.432% |
| Opyl Limited | -374.64 Thousand AUD | -2732.949% |
| PainChek Limited | -3.56 Million AUD | -197.999% |
| Pro Medicus Limited | -57.99 Million AUD | 81.699% |
| Resonance Health Limited | -3.68 Million AUD | -188.294% |
| Singular Health Group Ltd | -1.23 Million AUD | -759.458% |
| Total Brain Limited | 500.22 Thousand AUD | 2221.737% |